Intelligence · Clinical Development
Pipeline search results
Programs matching “Novartis” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 341 pipeline programs matching "Novartis" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Ribociclib
Novartis Pharmaceuticals
Advanced, Metastatic Breast Cancer
1 trial -
Ribociclib
Novartis Pharmaceuticals
Breast Cancer
1 trial -
Ruxolitinib
Novartis Pharmaceuticals
Polycythemia Vera
1 trial -
SECUKINUMAB
Novartis Pharmaceuticals
Polymyalgia Rheumatica
1 trial -
SEG101
Novartis Pharmaceuticals
Sickle cell disease
1 trial -
Secukinumab
Novartis Pharmaceuticals
Plaque Psoriasis
1 trial -
Secukinumab
Novartis Pharmaceuticals
Psoriatic Arthritis
2 trials -
Secukinumab
Novartis Pharmaceuticals
Ankylosing Spondylitis
1 trial -
Secukinumab (75 mg)
Novartis Pharmaceuticals
Psoriatic Arthritis
1 trial -
TQJ230
Novartis Pharmaceuticals
Atherosclerotic cardiovascular disease (ASCVD)
1 trial -
Telbivudine
Novartis Pharmaceuticals
Hepatitis
1 trial -
VAY736
Novartis Pharmaceuticals
Sjogren Syndrome
1 trial -
VAY736F12301E1
Novartis Pharmaceuticals
Systemic Lupus Erythematosus
1 trial -
Vildagliptin
Novartis Pharmaceuticals
Diabetes Mellitus, Type 2
1 trial -
Vildagliptin
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus
1 trial -
Zoledronic acid
Novartis Pharmaceuticals
Osteoporosis
1 trial -
Zoledronic acid
Novartis Pharmaceuticals
Breast Cancer
1 trial -
Zolgensma 2 × 10^13 vector genomes/mL solution for infusion
Novartis Pharmaceuticals
Spinal Muscular Atrophy
1 trial -
canakinumab
Novartis Pharmaceuticals
Non-small Cell Lung Cancer
2 trials -
ianalumab
Novartis Pharmaceuticals
Systemic Lupus Erythematosus
1 trial -
ianalumab s.c. q4w
Novartis Pharmaceuticals
Lupus Nephritis
1 trial -
secukinumab
Novartis Pharmaceuticals
Lupus Nephritis
1 trial -
telbivudine or lamivudine
Novartis Pharmaceuticals
Chronic Hepatitis B
1 trial -
zigakibart
Novartis Pharmaceuticals
Kidney Diseases
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.